The invention provides methods of identifying compounds that inhibit
specific tRNA:34A deaminases encoded by yfhC genes, compounds that
inhibit such deaminases and methods of using the deaminases in a variety
of in vitro and in vivo contexts, such as in the treatment and prevention
of bacterial infections.
